By
Vish Srivastava2025-10-20T09:00:00
Vish Srivastava considers the benefits of expanding the role of real-world data in drug discovery to provide improved therapies, faster and with greater success.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
2023-09-27T10:36:50
Sponsored by NanoTemper Technologies
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2025-05-14T14:30:00
Sponsored by Abzena
2023-07-03T10:28:23
Sponsored by Merck
Site powered by Webvision Cloud